The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center
<i>Background and Objectives:</i> An increasing incidence of non-melanoma skin cancer (NMSC) is noted, as well as an increasing cost of the treatment, with NMSC becoming a public health problem. We aimed to investigate the prevalence and treatment costs of surgically treated NMSC from th...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-01-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/59/2/220 |
| _version_ | 1827756566971940864 |
|---|---|
| author | Cosmin Ioan Faur Mădălina Anca Moldovan Mădălina Văleanu Horațiu Rotar Laura Filip Rareș Călin Roman |
| author_facet | Cosmin Ioan Faur Mădălina Anca Moldovan Mădălina Văleanu Horațiu Rotar Laura Filip Rareș Călin Roman |
| author_sort | Cosmin Ioan Faur |
| collection | DOAJ |
| description | <i>Background and Objectives:</i> An increasing incidence of non-melanoma skin cancer (NMSC) is noted, as well as an increasing cost of the treatment, with NMSC becoming a public health problem. We aimed to investigate the prevalence and treatment costs of surgically treated NMSC from the Oral and Maxillofacial Surgery Department of Cluj-Napoca County Hospital. <i>Materials and Methods:</i> We retrospectively analyzed the clinical data and the charge data of hospitalization from the informatic system of Cluj-Napoca County Hospital. All patients benefited from standard surgical excision with the reconstruction of the post-excisional defect. A statistical analysis of the costs related to the patients’ features, period and conditions of hospitalization, materials, medication, and paraclinical investigations was performed. <i>Results:</i> Between 2015 and 2019, 133 patients with NMSC were addressed to our department, with basal cell carcinoma (BCC) being four-fold higher than squamous cell carcinoma (SCC). Most NMSC cases were diagnosed in stage I or II, and they benefited from local reconstruction. The treatment costs progressively increased in the last five years, reaching a total cost of EUR ~13.000 in 2019. The treatment cost per episode was higher for SCC compared to BCC, while the total cost of treatment in 5 years was higher for BCC. Low income, immunosuppression, comorbidities, flap reconstruction option, long-lasting surgery, and prolonged hospitalization were associated with an increased cost of the treatment. <i>Conclusion:</i> The prevalence and treatment cost of surgically treated NMSC of the head and neck region increased in the last five years, with high-cost drivers being related to patients and treatment options. |
| first_indexed | 2024-03-11T08:27:11Z |
| format | Article |
| id | doaj.art-480c7bceb3ba4273926eff407e56d5b4 |
| institution | Directory Open Access Journal |
| issn | 1010-660X 1648-9144 |
| language | English |
| last_indexed | 2024-03-11T08:27:11Z |
| publishDate | 2023-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj.art-480c7bceb3ba4273926eff407e56d5b42023-11-16T21:58:46ZengMDPI AGMedicina1010-660X1648-91442023-01-0159222010.3390/medicina59020220The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial CenterCosmin Ioan Faur0Mădălina Anca Moldovan1Mădălina Văleanu2Horațiu Rotar3Laura Filip4Rareș Călin Roman5Department of Maxillofacial Surgery and Radiology, Oral and Cranio-Maxillofacial Surgery, “Iuliu Hațieganu” University of Medicine and Pharmacy, 33 Moților Street, 400001 Cluj-Napoca, RomaniaDepartment of Maxillofacial Surgery and Radiology, Oral and Cranio-Maxillofacial Surgery, “Iuliu Hațieganu” University of Medicine and Pharmacy, 33 Moților Street, 400001 Cluj-Napoca, RomaniaDepartment of Medical Informatics and Biostatistics, “Iuliu Hatieganu” University of Medicine and Pharmacy, 6 Pasteur Street, 400012 Cluj-Napoca, RomaniaDepartment of Maxillofacial Surgery and Radiology, Oral and Cranio-Maxillofacial Surgery, “Iuliu Hațieganu” University of Medicine and Pharmacy, 33 Moților Street, 400001 Cluj-Napoca, RomaniaDepartment of Maxillofacial Surgery and Radiology, Oral and Cranio-Maxillofacial Surgery, “Iuliu Hațieganu” University of Medicine and Pharmacy, 33 Moților Street, 400001 Cluj-Napoca, RomaniaDepartment of Maxillofacial Surgery and Radiology, Oral and Cranio-Maxillofacial Surgery, “Iuliu Hațieganu” University of Medicine and Pharmacy, 33 Moților Street, 400001 Cluj-Napoca, Romania<i>Background and Objectives:</i> An increasing incidence of non-melanoma skin cancer (NMSC) is noted, as well as an increasing cost of the treatment, with NMSC becoming a public health problem. We aimed to investigate the prevalence and treatment costs of surgically treated NMSC from the Oral and Maxillofacial Surgery Department of Cluj-Napoca County Hospital. <i>Materials and Methods:</i> We retrospectively analyzed the clinical data and the charge data of hospitalization from the informatic system of Cluj-Napoca County Hospital. All patients benefited from standard surgical excision with the reconstruction of the post-excisional defect. A statistical analysis of the costs related to the patients’ features, period and conditions of hospitalization, materials, medication, and paraclinical investigations was performed. <i>Results:</i> Between 2015 and 2019, 133 patients with NMSC were addressed to our department, with basal cell carcinoma (BCC) being four-fold higher than squamous cell carcinoma (SCC). Most NMSC cases were diagnosed in stage I or II, and they benefited from local reconstruction. The treatment costs progressively increased in the last five years, reaching a total cost of EUR ~13.000 in 2019. The treatment cost per episode was higher for SCC compared to BCC, while the total cost of treatment in 5 years was higher for BCC. Low income, immunosuppression, comorbidities, flap reconstruction option, long-lasting surgery, and prolonged hospitalization were associated with an increased cost of the treatment. <i>Conclusion:</i> The prevalence and treatment cost of surgically treated NMSC of the head and neck region increased in the last five years, with high-cost drivers being related to patients and treatment options.https://www.mdpi.com/1648-9144/59/2/220non-melanoma skin cancerhead and neck cancerhospitalization costs |
| spellingShingle | Cosmin Ioan Faur Mădălina Anca Moldovan Mădălina Văleanu Horațiu Rotar Laura Filip Rareș Călin Roman The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center Medicina non-melanoma skin cancer head and neck cancer hospitalization costs |
| title | The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
| title_full | The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
| title_fullStr | The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
| title_full_unstemmed | The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
| title_short | The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
| title_sort | prevalence and treatment costs of non melanoma skin cancer in cluj napoca maxillofacial center |
| topic | non-melanoma skin cancer head and neck cancer hospitalization costs |
| url | https://www.mdpi.com/1648-9144/59/2/220 |
| work_keys_str_mv | AT cosminioanfaur theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT madalinaancamoldovan theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT madalinavaleanu theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT horatiurotar theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT laurafilip theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT rarescalinroman theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT cosminioanfaur prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT madalinaancamoldovan prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT madalinavaleanu prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT horatiurotar prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT laurafilip prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT rarescalinroman prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter |